Open AccessAbstract 1805: Antitumor activity of lenvatinib mesilate in human hepatocellular carcinoma preclinical models
Author(s) -
Masahiro Matsuki,
Yuji Yamamoto,
Taisuke Hoshi,
Takayuki Kimura,
Yasuhiro Funahashi,
Junji Matsui
Publication year - 2017
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2017-1805
Subject(s) - lenvatinib , sorafenib , cancer research , hepatocellular carcinoma , fibroblast growth factor receptor 4 , fibroblast growth factor receptor 1 , pharmacology , growth factor receptor , cell growth , medicine , fgf19 , tyrosine kinase , receptor tyrosine kinase , tyrosine kinase inhibitor , cancer , fibroblast growth factor , receptor , fibroblast growth factor receptor , chemistry , biochemistry